Document ID: chunk:federal_register_of_legislation:C2021A00139:clause:1_104b:p2
Version: federal_register_of_legislation:C2021A00139
Segment Type: clause
Provision Reference: sch 1 cl 104B (pt 2/2)
Character Range: 56714–57452

amount worked out using the following formula:
where:
AEMP1 means the amount the approved ex‑manufacturer price of the brand of the pharmaceutical item would be on 1 October 2022 if the pricing quantity had not changed.
PQ1 means the pricing quantity of the brand of the pharmaceutical item on the day before 1 October 2022.
PQ2 means the pricing quantity of the brand of the pharmaceutical item on 1 October 2022.

Section does not limit Minister's powers
 (8) This section does not limit the Minister's powers, on or after 1 October 2022, to make:
 (a) price agreements; or
 (b) determinations under section 85B;
in relation to the brand of the pharmaceutical item.

Part 4—Amendments commencing on 1 July 2023

National Health Act 1953